The Pasteur Network 2024–2025 Biennial Report: Two Years of Collective Action for Global Health

We are pleased to announce that the Pasteur Network 2024–2025 Biennial Report is now available online. It captures two years of collective work across our alliance of more than 30 institutes, 5,000 researchers, engineers, and technicians, working across 25 countries on five continents; united by a single mission: science in the service of public health.

This report also marks a leadership transition. We warmly thank Amadou Sall for his presidency from 2020 to 2024, and welcome Mario Moreira (President, Fiocruz) as our new President, alongside Yasmine Belkaid (President, Institut Pasteur, Paris) as Vice President, under the continued leadership of Executive Director Rebecca Grais.

Strengthening Epidemic Preparedness

The Network mobilized rapidly in response to the WHO declaration of Mpox as a Public Health Emergency, strengthened avian influenza surveillance across nine Asia-Pacific institutes, and was selected as Secretariat of the newly launched Collective Action on Dengue. Eighteen fellows from five continents are now developing climate and health research projects through the Climate and Health Observatory Accelerator. Through the DURABLE project, supported by the EU’s Health Emergency Preparedness and Response Authority, the Network also strengthened coordinated research and response capacities across European institutions. Building on a planning grant from the Gates Foundation, over 50 international experts convened in Lille in June 2025 to advance wastewater surveillance.

Advancing Research, Development, and Innovation

Key Network members signed a Memorandum of Understanding to accelerate mRNA vaccine research and development, with a focus on low- and middle-income countries. The Vaccine Manufacturing Initiative, supported by the Wellcome Trust, is building a shared ecosystem drawing on over 2,600 experts across nine countries and more than 525 million vaccine doses produced annually. A landmark partnership with the International Vaccine Institute was also formalized in June 2024.

Building Knowledge Communities

PNLink, the Network’s new digital knowledge-sharing platform, launched in October 2025 and reached 900 members by end of 2025. Scientific Working Groups opened collaboration to researchers at all career stages, many monthly seminars drew participants from across the Network, and the SPARK Program selected four international early-career research projects from 22 proposals received.

Reinforcing Governance and Equity

The PN Strategic Advisory Board, was created in 2024 to provide high-level guidance on partnerships, funding, and strategic direction,

The Network also adopted the TRUST Code for equitable research partnerships, approved a Collaboration Agreement defining shared principles and responsibilities among members, and established a framework for Associate Membership. Two flagship programs at Fiocruz and Institut Pasteur de Dakar advanced women’s leadership in science, together reaching over 180 beneficiaries and supporting 68 fellowships across academic levels.

Growing Our Partnerships

In 2024–2025, the Network renewed its status as a WHO Non-State Actor through 2027, joined the WHO International Pathogen Surveillance Network, and forged new partnerships with EUGLOH, the One Health – Emerging Infectious Diseases Graduate School at Université Paris Cité, the University of Hong Kong’s School of Public Health, and the PREZODE pandemic prevention initiative.